Quarterly report pursuant to Section 13 or 15(d)

Note 8 - Supplemental Equity and Accumulated Other Comprehensive Income (Loss) (Tables)

v3.19.3
Note 8 - Supplemental Equity and Accumulated Other Comprehensive Income (Loss) (Tables)
3 Months Ended
Sep. 30, 2019
Notes Tables  
Consolidated Stockholders' Equity Statement [Table Text Block]
   

 

           

 

   

Accumulated

         
                   

Additional

           

Other

         
    Common Stock    

Paid-in

    Retained    

Comprehensive

         
   

Shares

   

Amount

   

Capital

   

Earnings

   

Income(Loss)

   

Total

 

Balances at June 30, 2019

    37,934      $ 379      $ 316,797      $ 931,934      $ (83,521 )   $ 1,165,589  

Cumulative effect adjustments due to adoption of new accounting standards and other

                            (879 )             (879 )

Net earnings

                            14,398               14,398  

Other comprehensive loss

                                    (8,106 )     (8,106 )

Common stock issued for exercise of options

    94       1       7,854                       7,855  

Common stock issued for restricted stock awards

    50       0       (0 )     (1,926 )             (1,926 )

Cash dividends

                            (12,169 )             (12,169 )

Stock-based compensation expense

                    8,267                       8,267  

Common stock issued to employee stock purchase plan

    6       0       1,096                       1,096  

Employee stock purchase plan expense

                    99                       99  

Balances at September 30, 2019

    38,084      $ 381      $ 334,112      $ 931,358      $ (91,627 )   $ 1,174,224  
   

 

           

 

   

Accumulated

         
                   

Additional

           

Other

         
    Common Stock    

Paid-in

    Retained    

Comprehensive

         
   

Shares

   

Amount

   

Capital

   

Earnings

   

Income(Loss)

   

Total

 

Balances at June 30, 2018

    37,608     $ 376     $ 246,568     $ 876,931     $ (44,814

)

  $ 1,079,061  

Cumulative effect adjustments due to adoption of new accounting standards and other

                            25,276       (24,682

)

    594  

Net earnings

                            17,403               17,403  

Other comprehensive loss

                                    (1,136

)

    (1,136

)

Common stock issued for exercise of options

    166       2       15,609                       15,611  

Common stock issued for restricted stock awards

    24       0               (2,405

)

            (2,405

)

Cash dividends

                            (12,066

)

            (12,066

)

Stock-based compensation expense

                    11,327                       11,327  

Common stock issued to employee stock purchase plan

    5       0       842                       842  

Employee stock purchase plan expense

                    238                       238  

Balances at September 30, 2018

    37,803     $ 378     $ 274,584     $ 905,139     $ (70,632

)

  $ 1,109,469  
Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]
   

Unrealized

Gains

(Losses) on

Derivative Instruments

   

Foreign

Currency

Translation

Adjustments

   

Total

 

Balance as of June 30, 2019

  $ (9,537 )   $ (73,983

)

  $ (83,521

)

Other comprehensive income (loss), net of tax before reclassifications

    (504 )     (7,602

)

    (8,106

)

Balance as of September 30, 2019(1)

  $ (10,041 )   $ (81,585

)

  $ (91,627

)

   

Unrealized

Gains

(Losses) on

Derivative Instruments

   

Foreign

Currency

Translation

Adjustments

   

Total

 

Balance as of June 30, 2018(2)

  $ -     $ (69,496

)

  $ (69,496

)

Other comprehensive income (loss), net of tax before reclassifications

    -       (1,136

)

    (1,136

)

Balance as of September 30, 2018

  $ -     $ (70,632

)

  $ (70,632

)